Showing results (661-670 of 690) with videos related to

Sort By:
Pageof 69
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Open Forum Infectious Diseases|June 23, 2023
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in JapanTakeshi Arashiro, Yuzo Arima, Jin Kuramochi, et al.
Annals of Nuclear Medicine|October 10, 2020
Comparison of <sup>18</sup>F-FDG PET/CT and <sup>67</sup>Ga-SPECT for the diagnosis of fever of unknown origin: a multicenter prospective study in JapanKazuo Kubota, Noriko Tanaka, Yoko Miyata, et al.
Science (New York, N.Y.)|November 13, 2020
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivoYixuan J Hou, Shiho Chiba, Peter Halfmann, et al.
Immunity|July 11, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.
Nature|March 17, 2017
Strongly baryon-dominated disk galaxies at the peak of galaxy formation ten billion years agoR Genzel, N M Förster Schreiber, H Übler, et al.
Immunity|September 11, 2021
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable siteTaishi Onodera, Shunsuke Kita, Yu Adachi, et al.
Med (New York, N.Y.)|March 9, 2022
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variantsSho Miyamoto, Takeshi Arashiro, Yu Adachi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure developmentMasaki Imai, Kiyoko Iwatsuki-Horimoto, Masato Hatta, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
Pageof 69